Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added to the related topics section of the study page, enhancing disease context and links to patient resources.
    Difference
    0.2%
    Check dated 2026-05-01T09:09:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The study record reflects an update to outcome-measure definitions and timelines (e.g., RECIST response assessment at 12 weeks and follow-up, PFS/OS timepoints, and safety/tolerability reporting windows) along with corresponding eligibility-criteria text describing required health status and reproductive-contraception requirements. It also updates the record’s “results posted”/last-updated metadata associated with the April 2026 posting.
    Difference
    3%
    Check dated 2026-04-24T05:55:19.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision update applied to the page, replacing the previous revision with a newer version.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:40.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Removed 'Melanoma' and 'MedlinePlus Genetics' from the related topics section.
    Difference
    0.2%
    Check dated 2026-04-09T21:01:41.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    MedlinePlus Genetics is now listed in related topics, alongside Melanoma.
    Difference
    0.2%
    Check dated 2026-04-02T15:16:05.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:44:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.